drugset
drugset / Trial / NCT03922633

A Single Intravenous Dose of E3112 in Japanese Healthy Adult Male Participants

NCT03922633 ↗

Phase 1 Completed 24 enrolled EA Pharma Co., Ltd.
RandomizedCrossoverQuadruple-blindBasic science

Summary

The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics after a single intravenous dose of E3112 in Japanese healthy adult male participants.

Timeline

Start
2019-04-22
Primary completion
2020-05-20
Completion
2020-10-01

Drugs

EvaluationDrugModalityDoseRoute
Subject E3112 Unknown — Intravenous

Indications

No indication recorded.